Blue Light Cystoscopy System Approved for Marketing in China; “Blue Light Era” for Precision Treatment of Bladder Cancer Begins

[April 24, Beijing] Recently, SYSTEM BLUE, a blue light cystoscopy system from Richard Wolf GmbH (a partner of Asieris Pharmaceuticals), received marketing approval from the National Medical Products Administration (NMPA) in China. This system, used in combination with Asieris Pharmaceuticals’ previously approved blue light imaging agent, Hexvix®, forms a complete “Blue Light Combination” for the […] The post Blue Light Cystoscopy System Approved for Marketing in China; “Blue Light Era” for Precision Treatment of Bladder Cancer Begins appeared first on Asieris Pharmaceuticals .